Incyte INCY suffered a setback in its ongoing mid-stage study on MRGPRX2 (INCB000262) in chronic spontaneous urticaria (CSU).

Dupilumab (Dupixent), a fully human monoclonal antibody that targets the interleukin (IL)-4 and IL-13 pathways, is currently ...

Itchy breasts and nipples can be an uncomfortable experience that disrupts daily life. While occasional itching may seem ...

The US Food and Drug Administration (FDA) has accepted a resubmission of the supplemental Biologics License Application for ...

The drugmaker put the idea to the test in a phase 3 trial that randomized PBC patients with moderate to severe itch to ...

The trial recruited PBC patients with moderate to severe itch, who were receiving stable doses of guideline-suggested therapies for pruritus, or were treatment naive, or had been previously treated.

Surveys were conducted across several European countries to assess the prevalence, symptoms, treatment, and impact of CKD-aP on patients' quality of life. Findings are clear: over two-thirds of CKD-aP ...

The primary efficacy outcome was treatment response rate at the end of period 1 (defined as a xerosis ... While changes in pruritus severity over time for both uremic xerosis and chronic kidney ...

Former customer Keri Jimenez said thought she was getting top-notch beauty treatments. Instead, she found herself facing questionable results, severe side effects, and a lot of unanswered questions.

including inflammation and itching. Leukotriene inhibitors, such as Singulair (montelukast) or Accolate (zafirlukast), may be used off-label for the treatment of eczema. However, the benefits of such ...

Damaging wind gusts were the main threat with multiple reports of 70-plus mph winds. A 90-mph wind gust was recorded in Falls City, Nebraska. What's left of these severe storms remains ongoing ...